
Sign up to save your podcasts
Or
I sat down with Jane Lyons, Country Manager, PharmaLex Ireland, andΒ European Co-Ordinator for Quality Management and Compliance, as part of my ongoing #ReflectionsandForecasts 2022/23 interview series.
We covered a wide range of topics including
#Hybridworking, #Onshoring, #BREXIT, #ATMPS, #AI, #Blockchain, #ANNEX1, #outsourcing and more.
I asked her....
2022 ππππ₯ππππ’π¨π§π¬Β
β’ Β Can you give me a quick overview of #PharmaLex? 00:55
β’ Β One word to describe 2022 and why? 02:04
β’ Β What were some of #PharmalexIrelands key achievements in 2022? 03:10
β’Β Β What has been client reactions to PharmaLex's continuing the hybrid working model 04:42
β’ Β Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 06:24
β’Β Β How easy it for countries to onshore their #Pharma #API manufacturing? 07:52
β’Β Β How much impact has BREXIT had on Pharma in the UK and Europe? 08:59
β’Β Β Are there any areas you think the industry could improve? 10:37
Β
2023 π π¨π«ππππ¬ππ¬
β’ Β What are your predictions for the #LifeScience, #Pharma and #BioPharma in 2023? 12:16
β’Β What developments and trends do you expect to see/predict in terms of regulation?Β 14:11
β’ Β What can we expect from Pharmalex Ireland in 2023? 16:19
β’ Β What is Janes view in terms of funding in the Pharma/ BioPharma in Europe in 2023? 17:25
β’Β Finally, what last thoughts would you like to leave viewers with for 2023? 19:36
π You WATCH the interview here https://lnkd.in/e6bX49r2
Please leave any questions or comments for Jane below.Β
You can find out more about PharmaLex Ireland at https://lnkd.in/dt_Fi9Vn
You can also reach out to Jane via LinkedIn and email her at [email protected]
π You can see Janes Reflections and Forecasts for last year hereΒ https://lnkd.in/eGtP9gxzΒ
I sat down with Jane Lyons, Country Manager, PharmaLex Ireland, andΒ European Co-Ordinator for Quality Management and Compliance, as part of my ongoing #ReflectionsandForecasts 2022/23 interview series.
We covered a wide range of topics including
#Hybridworking, #Onshoring, #BREXIT, #ATMPS, #AI, #Blockchain, #ANNEX1, #outsourcing and more.
I asked her....
2022 ππππ₯ππππ’π¨π§π¬Β
β’ Β Can you give me a quick overview of #PharmaLex? 00:55
β’ Β One word to describe 2022 and why? 02:04
β’ Β What were some of #PharmalexIrelands key achievements in 2022? 03:10
β’Β Β What has been client reactions to PharmaLex's continuing the hybrid working model 04:42
β’ Β Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 06:24
β’Β Β How easy it for countries to onshore their #Pharma #API manufacturing? 07:52
β’Β Β How much impact has BREXIT had on Pharma in the UK and Europe? 08:59
β’Β Β Are there any areas you think the industry could improve? 10:37
Β
2023 π π¨π«ππππ¬ππ¬
β’ Β What are your predictions for the #LifeScience, #Pharma and #BioPharma in 2023? 12:16
β’Β What developments and trends do you expect to see/predict in terms of regulation?Β 14:11
β’ Β What can we expect from Pharmalex Ireland in 2023? 16:19
β’ Β What is Janes view in terms of funding in the Pharma/ BioPharma in Europe in 2023? 17:25
β’Β Finally, what last thoughts would you like to leave viewers with for 2023? 19:36
π You WATCH the interview here https://lnkd.in/e6bX49r2
Please leave any questions or comments for Jane below.Β
You can find out more about PharmaLex Ireland at https://lnkd.in/dt_Fi9Vn
You can also reach out to Jane via LinkedIn and email her at [email protected]
π You can see Janes Reflections and Forecasts for last year hereΒ https://lnkd.in/eGtP9gxzΒ